rBIO Achieves Crucial Milestone on Mission to Lower the Cost of Insulin by 30%
rBIO Achieves Crucial Milestone on Mission to Lower the Cost of Insulin by 30%
20+ Years
20 Years
Of Experience
The Largest Network Of Laboratories provider of Testing Center.
Mauris ut enim sit amet lacus ornare ullamcorper. Praesent placerat neque eu purus rhoncus, vel tincidunt odio ultrices. Sed feugiat feugiat felis. Curabitur posuere tristique mauris non blandit. Sed consectetur venenatis enim, vitae vestibulum ipsum tincidunt in. Fusce et nulla vulputate, pellentesque leo non, bibendum orci.
Blood Bank & Chemistry Center
Chemical Research & Testing Center
Our Success Journey Choose We can Provide.
Mauris ut enim sit amet lacus ornare ullamcorper. Praesent placerat neque eu purus rhoncus, vel tincidunt odio ultrices. Sed feugiat feugiat felis. Curabitur posuere tristique mauris non blandit. Sed consectetur venenatis enim, vitae vestibulum ipsum tincidunt in. Fusce et nulla vulputate, pellentesque leo non, bibendum orci.
Improving Your Health
Trust Shared Purpose
Better Health Outcomes
Empowered to Change
Innovations In Vaccines
Strict Quality Practices
Sergej Djuranovic, Ph.D
Sergej Durakovic, Professor, Department of Cell Biology and Physiology, Washington University School of Medicine. focused on understanding the basic mechanisms of gene expression control at the level of mRNA translation with the objective of devising new strategies for drug development.
Harry Ramos
Harry Ramos is Former Marine and Mayor with 14 years government experience and 10 years in key leadership roles developing technology companies.
Judith Shizuru, MD
Judith Shizuru is a member of the Stanford Blood and Marrow Transplantation faculty, the Stanford Immunology Program, the Institute of Stem Cell Biology and Regenerative Medicine, and oversees a research laboratory within the University. Judy spun out some of her research to form the company, Jasper Therapeutics, in 2016, which has raised >$100M to date and IPO’d in 2021.
Stuart Douglass
Stuart Douglass draws his experince from nearly 30 years in the tools and manufacturing business. He has direct experience in the design and construction of multiple manufacturing facilities; having done this serveral times in similar industries. Stu also assisted in the writing a provisional patent for the ‘Purification Process for Large Scale Manufacturing of Recombinant DNA Molecules” specifically for insulin, which was filed in November 2021.